Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Haemophilia and cancer: a personal perspective.

× No keyword cloud information.

41 in total

1. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.

Authors: S C Darby; D W Ewart; P L Giangrande; R J Spooner; C R Rizza; G M Dusheiko; C A Lee; C A Ludlam; F E Preston
Journal: Lancet Date: 1997-11-15 Impact factor: 79.321

2. Clinical characteristics and blood product usage in AIDS-associated lymphoma in haemophiliacs: a case-control study.

Authors: M V Ragni; S H Belle; D Bass; S Duerstein; L A Kingsley
Journal: Haemophilia Date: 1998-11 Impact factor: 4.287

3. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75.

Authors: L R Zacharski; W G Henderson; F R Rickles; W B Forman; C J Cornell; R J Forcier; R L Edwards; E Headley; S H Kim; J F O'Donnell
Journal: Cancer Date: 1984-05-15 Impact factor: 6.860

4. Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia.

Authors: M V Ragni; S H Belle; R A Jaffe; S L Duerstein; D C Bass; C W McMillan; E W Lovrien; L M Aledort; C T Kisker; S P Stabler
Journal: Blood Date: 1993-04-01 Impact factor: 22.113

5. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

Authors: Ajay K Kakkar; Mark N Levine; Zbigniew Kadziola; Nicholas R Lemoine; Vanessa Low; Heman K Patel; Gordon Rustin; Michael Thomas; Mary Quigley; Robin C N Williamson
Journal: J Clin Oncol Date: 2004-05-15 Impact factor: 44.544

6. Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.

Authors: L H Maurer; J E Herndon; D R Hollis; J Aisner; R W Carey; A T Skarin; M C Perry; W L Eaton; L L Zacharski; S Hammond; M R Green
Journal: J Clin Oncol Date: 1997-11 Impact factor: 44.544

7. Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada.

Authors: I R Walker; J A Julian
Journal: Haemophilia Date: 1998-09 Impact factor: 4.287

8. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.

Authors: M Altinbas; H S Coskun; O Er; M Ozkan; B Eser; A Unal; M Cetin; S Soyuer
Journal: J Thromb Haemost Date: 2004-08 Impact factor: 5.824

9. Treatment with coumarin to prevent or delay recurrence of malignant melanoma.

Authors: R D Thornes; L Daly; G Lynch; B Breslin; H Browne; H Y Browne; T Corrigan; P Daly; G Edwards; E Gaffney
Journal: J Cancer Res Clin Oncol Date: 1994 Impact factor: 4.553

10. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

Authors: M Levine; J Hirsh; M Gent; A Arnold; D Warr; A Falanga; M Samosh; V Bramwell; K I Pritchard; D Stewart
Journal: Lancet Date: 1994-04-09 Impact factor: 79.321

2 in total

Review 1. Clinical use of factor VIII and factor IX concentrates.

Authors: Massimo Morfini; Antonio Coppola; Massimo Franchini; Giovanni Di Minno
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

2. Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial.

Authors: Ralph Gruppo; Maria-Fernanda López-Fernández; Tung T Wynn; Werner Engl; Marlies Sharkhawy; Srilatha Tangada
Journal: Haemophilia Date: 2019-07-28 Impact factor: 4.287

2 in total